Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model

- Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.

Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model

- Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly, McCluskey, Adam, Garg, Sanjay, Page, Stephen W., Trott, Darren J., Ogunniyi, Abiodun D.

Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology

- Nguyen, Hang Thi, O'Donovan, Lisa A., Venter, Henrietta, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Trott, Darren J., Ogunniyi, Abiodun D.

In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens

- Nguyen, Hang Thi, Venter, Henrietta, Veltman, Tania, Williams, Ruth, O'Donovan, Lisa Anne, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.

In vitro activity of robenidine analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice

- Pi, Hongfei, Nguyen, Hang Thi, Venter, Henrietta, Boileau, Alexandra R., Woolford, Lucy, Garg, Sanjay, Page, Stephen W., Russell, Cecilia C., Baker, Jennifer R., McCluskey, Adam, O'Donovan, Lisa A., Trott, Darren J., Ogunniyi, Abiodun D.